Wellness

A global analysis finds that aging populations may face intolerable heat more often, in more places, and for longer than previous estimates showed.

The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts share why it’s considered a massive leap forward for skin health in the U.S.

Peptides are everywhere online, touted for looksmaxxing, muscle building, and weight loss. Stanford Medicine experts explain what is – and isn’t – backed by evidence.

Millions of Americans use compounded versions of GLP-1s to save money. Stanford Medicine experts explain what makes them different from FDA-approved versions.

How do the drugs work? What happens if you stop? Is it safe to take them long term? Clinicians share everything you need to know about GLP-1 agonists.

New research reveals that racial bias in pulse oximeters leads to significant disparities in follow-up care between Black and white patients.

A study led by Stanford researchers highlights the effectiveness of an AI health coaching app in fostering user autonomy and motivation.

A $10 million commitment aims to help the American Cancer Society build a new Hope Lodge, providing temporary lodging for cancer patients traveling to the Bay Area for treatment.

A Stanford study shows simple digital prompts can motivate people taking GLP-1 medications to make lifestyle changes.

Establishing a foundation of exercise, nutrition, sleep, and stress management early on is crucial for long-term health, according to Stanford Medicine experts.